RAPT Therapeutics, Inc. (RAPT) Other Working Capital Changes (2020 - 2024)
RAPT Therapeutics (RAPT) has disclosed Other Working Capital Changes for 5 consecutive years, with -$1.1 million as the latest value for Q4 2024.
- Quarterly Other Working Capital Changes rose 28.95% to -$1.1 million in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$2.9 million through Dec 2024, down 5.47% year-over-year, with the annual reading at -$2.9 million for FY2024, 5.47% down from the prior year.
- Other Working Capital Changes hit -$1.1 million in Q4 2024 for RAPT Therapeutics, down from -$286000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $4.4 million in Q4 2021 to a low of -$2.7 million in Q3 2021.
- Historically, Other Working Capital Changes has averaged -$78444.4 across 5 years, with a median of -$447000.0 in 2020.
- Biggest five-year swings in Other Working Capital Changes: soared 442.86% in 2021 and later tumbled 525.32% in 2023.
- Year by year, Other Working Capital Changes stood at -$1.3 million in 2020, then skyrocketed by 442.86% to $4.4 million in 2021, then crashed by 33.6% to $2.9 million in 2022, then tumbled by 154.72% to -$1.6 million in 2023, then grew by 28.95% to -$1.1 million in 2024.
- Business Quant data shows Other Working Capital Changes for RAPT at -$1.1 million in Q4 2024, -$286000.0 in Q3 2024, and -$1.9 million in Q2 2024.